What is the typical remission rate for acute myeloid leukemia (AML)?

Prepare for the Adult-Gerontology Acute Care Nurse Practitioner Test. Study with interactive quizzes and detailed explanations. Boost your exam readiness with our diverse question formats and in-depth content coverage.

Multiple Choice

What is the typical remission rate for acute myeloid leukemia (AML)?

In AML, the induction attempt to put blasts into remission often yields a complete remission in roughly half to most patients treated, especially in younger, fit adults. With standard induction regimens (for example, cytarabine plus an anthracycline), about 60–70% of younger adults achieve complete remission, and rates can reach around 70–80% in those with favorable cytogenetics or excellent performance status. In older patients, remission rates are lower, reflecting more adverse biology and comorbidity, but the overall, typical range across a broad adult population generally falls between 50% and 80%. Remission here means the disease appears to be under control after induction: marrow blasts reduced to less than 5%, normalization of peripheral blood counts, and recovery of hematopoiesis. It’s important to keep in mind that remission does not equal cure—many patients relapse, and long-term outcomes depend on cytogenetics/molecular features and subsequent consolidation therapy. So, the 50–80% range best reflects the typical remission rate after standard induction in adults with AML.

In AML, the induction attempt to put blasts into remission often yields a complete remission in roughly half to most patients treated, especially in younger, fit adults. With standard induction regimens (for example, cytarabine plus an anthracycline), about 60–70% of younger adults achieve complete remission, and rates can reach around 70–80% in those with favorable cytogenetics or excellent performance status. In older patients, remission rates are lower, reflecting more adverse biology and comorbidity, but the overall, typical range across a broad adult population generally falls between 50% and 80%.

Remission here means the disease appears to be under control after induction: marrow blasts reduced to less than 5%, normalization of peripheral blood counts, and recovery of hematopoiesis. It’s important to keep in mind that remission does not equal cure—many patients relapse, and long-term outcomes depend on cytogenetics/molecular features and subsequent consolidation therapy.

So, the 50–80% range best reflects the typical remission rate after standard induction in adults with AML.

More practice questions